Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
Nature Communications · 2024
DOI: 10.1038/s41467-024-45075-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature Communications, 2024. Verfasst von Guoli Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. Hauptthemen laut MEDLINE: Interferons, COVID-19. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program, NIH, National Cancer Institute, Center for Cancer Research. Intramural Targeted anti-COVID19 Program, NIAID., Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Omicron emerged following COVID-19 vaccination campaigns, displaced previous SARS-CoV-2 variants of concern worldwide, and gave rise to lineages that continue to spread. Here, we show that Omicron exhibits increased infectivity in primary adult upper airway tissue relative to Delta. Using recombinant forms of SARS-CoV-2 and nasal epithelial cells cultured at the liquid-air interface, we show that mutations unique to Omicron Spike enable enhanced entry into nasal tissue. Unlike earlier variants of SARS-CoV-2, our findings suggest that Omicron enters nasal cells independently of serine transmembrane proteases and instead relies upon metalloproteinases to catalyze membrane fusion. Furthermore, we demonstrate that this entry pathway unlocked by Omicron Spike enables evasion from constitutive and interferon-induced antiviral factors that restrict SARS-CoV-2 entry following attachment. Therefore, the increased transmissibility exhibited by Omicron in humans may be attributed not only to its evasion of vaccine-elicited adaptive immunity, but also to its superior invasion of nasal epithelia and resistance to the cell-intrinsic barriers present therein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
- Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
- HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. alex.compton@nih.gov.
ORCID-Profile: Kin Kui Lai, Alex A Compton
Förderung
- Intramural Research Program, NIH, National Cancer Institute, Center for Cancer Research. Intramural Targeted anti-COVID19 Program, NIAID.
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Shi, G., Li, T., Lai, K. K., Johnson, R. F., Yewdell, J. W., & Compton, A. A. (2024). Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. Nature Communications. https://doi.org/10.1038/s41467-024-45075-8
Vancouver
Shi G, Li T, Lai KK, Johnson RF, Yewdell JW, Compton AA. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. Nature Communications. 2024. doi:10.1038/s41467-024-45075-8
BibTeX
@article{Shi2024,
author = {Shi, Guoli and Li, Tiansheng and Lai, Kin Kui and Johnson, Reed F and Yewdell, Jonathan W and Compton, Alex A},
title = {Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue},
journal = {Nature Communications},
year = {2024},
doi = {10.1038/s41467-024-45075-8}
}
EUVIMED